These observations suggest a seemingly ambiguous involvement of CCN1 in NASH: promoting steatosis by LD accumulation in parenchymal hepatocytes, but counteracting NASH-associated fibrosis by mediating senescence, in non-parenchymal HSCs and myofibroblasts. This evidence concerns the gene CCN1 and metabolic dysfunction-associated steatohepatitis.